Thiobacillus ferrooxidans is a extremely acidophilic and obligately chemlithotrophic bacterium. It is the most important work for gene engineering of T.ferrooxidans to develop an efficient gene transfer systems. This ...Thiobacillus ferrooxidans is a extremely acidophilic and obligately chemlithotrophic bacterium. It is the most important work for gene engineering of T.ferrooxidans to develop an efficient gene transfer systems. This paper summarized the genetics background of T.ferrooxidans, the process of establishing such a kind of gene transfer system, and its application in constructing arsenic resistance genetically engineered bacteria. Ref展开更多
The adoptive transfer of T cells is a promising approach to treat cancers. Primary human T cells can be modified using viral and non-viral vectors to promote the specific targeting of cancer cells via the introduction...The adoptive transfer of T cells is a promising approach to treat cancers. Primary human T cells can be modified using viral and non-viral vectors to promote the specific targeting of cancer cells via the introduction of exogenous T-cell receptors(TCRs) or chimeric antigen receptors(CARs). This gene transfer displays the potential to increase the specificity and potency of the anticancer response while decreasing the systemic adverse effects that arise from conventional treatments that target both cancerous and healthy cells. This review highlights the generation of clinical-grade T cells expressing CARs for immunotherapy, the use of these cells to target B-cell malignancies and, particularly, the first clinical trials deploying the Sleeping Beauty gene transfer system, which engineers T cells to target CD19+ leukemia and non-Hodgkin's lymphoma.展开更多
文摘Thiobacillus ferrooxidans is a extremely acidophilic and obligately chemlithotrophic bacterium. It is the most important work for gene engineering of T.ferrooxidans to develop an efficient gene transfer systems. This paper summarized the genetics background of T.ferrooxidans, the process of establishing such a kind of gene transfer system, and its application in constructing arsenic resistance genetically engineered bacteria. Ref
文摘The adoptive transfer of T cells is a promising approach to treat cancers. Primary human T cells can be modified using viral and non-viral vectors to promote the specific targeting of cancer cells via the introduction of exogenous T-cell receptors(TCRs) or chimeric antigen receptors(CARs). This gene transfer displays the potential to increase the specificity and potency of the anticancer response while decreasing the systemic adverse effects that arise from conventional treatments that target both cancerous and healthy cells. This review highlights the generation of clinical-grade T cells expressing CARs for immunotherapy, the use of these cells to target B-cell malignancies and, particularly, the first clinical trials deploying the Sleeping Beauty gene transfer system, which engineers T cells to target CD19+ leukemia and non-Hodgkin's lymphoma.
